1. Signaling Pathways
  2. Neuronal Signaling
  3. Cholinesterase (ChE)
  4. AChE Isoform
  5. AChE Antagonist

AChE Antagonist

AChE Antagonists (3):

Cat. No. Product Name Effect Purity
  • HY-NP192
    Sericin
    Antagonist
    Sericin is an orally active globular protein produced by silkworm cocoons. Sericin inhibits the expression of COX2, iNOS, TLR4, MAPK and NF-κB; reduces the levels of IL-18, IL-1 and CCL2; antagonizes the activity of AChE; and downregulates the expression of Bcl-2. Sericin enhances the PI3K/AKT-mediated insulin signaling pathway. Sericin inhibits the activity of tyrosinase (Tyrosinase), scavenges ROS, chelates metal ions, and increases the levels of antioxidant enzymes. Sericin induces apoptosis and arrests the cell cycle. Sericin exhibits antibacterial, moisturizing, cardioprotective and anticoagulant properties. Sericin can be used in research related to type 2 diabetes, hyperlipidemia, obesity, Alzheimer's disease, colon cancer, peripheral nerve injury and ischemic myocardial infarction.
  • HY-19181
    CI-1002
    Antagonist
    CI-1002 (PD 142676) is a potent acetylcholinesterase (AChE) and muscarinic antagonist. CI-1002 can be used for the study of the cognitive dysfunction of Alzheimer's disease (AD).
  • HY-B0732A
    Itopride
    Antagonist
    Itopride (HSR803 free base) is a potent and orally active dopamine-2 antagonist and an acetylcholine esterase (AChE) inhibitor. Itopride enhances gastric motility through both antidopaminergic and anti-acetylcholinesterasic actions, can be used as a gastrointestinal prokinetic agent. Itopride can be used for researching gastro-esophageal reflux disease (GERD).